Stratification analysis of TNF2 in comparison with HLA –B8
| Phenotype | Comparison with B8−/TNF2− | ||||
|---|---|---|---|---|---|
| B8 | TNF2 | PSC patients | Controls | OR (95%CI) | Probability pcorr |
| + | + | 42 | 30 | 4.3 (2.2–8.3) | 2×10-6 |
| + | − | 6 | 4 | 4.5 (1.0–15.6) | 0.06 |
| − | + | 14 | 17 | 2.5 (1.0–6.1) | 0.12 |
| − | − | 31 | 94 | ||
N=93 PSC patients and 145 controls.
PSC, primary sclerosing cholangitis.